Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Known cases of Diabetes Mellitus Type II and on medication showing symptoms of Prameha. 2) Patients with FBS 125mg/dl to 300 mg/dl and PPBS 140 mg/dl to 400 mg/dl (both inclusive) 3) Patients with HbA1C levels between 7.0 - 9.5 mg%
Exclusion criteria
Exclusion criteria: 1) Patients having FBS more than 300mg/dl PP2BS more than 400mg/dl HbA1C more than 9.5mg% 2) Patients showing acute complications and chronic complications - neuropathy, nephropathy, retinopathy. 3) Patients with Diabetes Mellitus Type I 4) Lactating and Pregnant Women 5) Patients with other systemic diseases - IHD, uncontrolled hypertension.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect on FBS, PP2BS and HbA1CTimepoint: Effect on FBS and PP2BS at baseline and after every 4 weeks till 12 weeks. Effect on HbA1C at baseline and at the end of 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Effect on symptoms of Prameha-Weakness (Daurbalya),Polyphagia(Kshudha vriddhi),Polydypsia (Pipasa vriddhi),Polyuria with turbidity in urine (Prabhuta Aavila Mutrata), Nocturnal micturition (Nakta Mutrata),Cramps (Pindikodvestana),Excess sweating(swedapravritti), Dyspnoea on exertion (Shwasakastata) Timepoint: Effect on symptoms at baseline and at the end of every 2 weeks till 12 weeks. | — |
Countries
India
Contacts
Parul Institute of Ayurved